Nonpharmacological Interventions for Mild Cognitive Impairment in Parkinson’s Disease
Embargo Lift Date
MetadataShow full item record
This research examined mild cognitive impairment in Parkinson’s Disease (PD-MCI) and the therapeutic potential of nonpharmacological interventions (e.g., cognitive training and transcranial direct current stimulation) for improving cognition, activities of daily living, and quality of life for people with PD-MCI. The results from this research suggest that cognitive training, tDCS, and cognitive training combined with tDCS may involve stimulation and compensation-focussed strategies that improve cognition, activities of daily living, and quality of life in PD-MCI.
Showing items related by title, author, creator and subject.
Cognitive Training and Transcranial Direct Current Stimulation for Mild Cognitive Impairment in Parkinson's Disease: A Randomized Controlled TrialLawrence, B.; Gasson, Natalie; Johnson, A.; Booth, L.; Loftus, A. (2018)Â© 2018 Blake J. Lawrence et al. This study examined whether standard cognitive training, tailored cognitive training, transcranial direct current stimulation (tDCS), standard cognitive training + tDCS, or tailored cognitive ...
Cognitive Training and Noninvasive Brain Stimulation for Cognition in Parkinson's Disease: A Meta-analysis.Lawrence, B.; Gasson, Natalie; Bucks, R.; Troeung, L.; Loftus, A. (2017)BACKGROUND: Many people with Parkinson's disease (PD) experience cognitive decline. It is not known whether cognitive training or noninvasive brain stimulation are effective at alleviating cognitive deficits in PD. ...
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.Porter, T.; Burnham, S.; Milicic, L.; Savage, G.; Maruff, P.; Lim, Y.; Li, Q.; Ames, D.; Masters, C.; Rainey-Smith, S.; Rowe, C.; Salvado, O.; Groth, D.; Verdile, Giuseppe; Villemagne, V.; Laws, S.; AIBL Research Group (2018)BACKGROUND: With the exception of APOE, genetic variants associated with increased Alzheimer's disease (AD) risk are characterized by small effect sizes. Polygenic risk scores (PRS) have shown utility in predicting AD ...